Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Xilio Therapeutics (XLO) Other Gross PP&E Adjustments (2024 - 2025)

Historic Other Gross PP&E Adjustments for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $6.8 million.

  • Xilio Therapeutics' Other Gross PP&E Adjustments rose 1313.13% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 1313.13%. This contributed to the annual value of $6.6 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Xilio Therapeutics' Other Gross PP&E Adjustments stood at $6.8 million, which was up 1313.13% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' Other Gross PP&E Adjustments registered a high of $7.0 million during Q2 2025, and its lowest value of $6.0 million during Q1 2024.